Please use this identifier to cite or link to this item: https://www.um.edu.mt/library/oar/handle/123456789/23270
Full metadata record
DC FieldValueLanguage
dc.contributor.authorAsher, M. Innes
dc.contributor.authorMontefort, Stephen
dc.contributor.authorBjorksten, Bengt
dc.contributor.authorLai, Christopher K. W.
dc.contributor.authorStrachan, David P.
dc.contributor.authorWilliams, Hywel
dc.contributor.authorWeiland, Stephan K.
dc.date.accessioned2017-10-31T15:30:21Z
dc.date.available2017-10-31T15:30:21Z
dc.date.issued2006
dc.identifier.citationAsher, M. I., Montefort, S., Bjorksten, B., Lai, C. K., Strachan, D. P., Weiland, S. K.,... ISAAC Phase Three Study Group. (2006). Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phases One and Three repeat multicountry cross-sectional surveys. The Lancet, 368(9537), 733-743.en_GB
dc.identifier.urihttps://www.um.edu.mt/library/oar//handle/123456789/23270
dc.description.abstractBackground: Data for trends in prevalence of asthma, allergic rhinoconjunctivitis, and eczema over time are scarce. We repeated the International Study of Asthma and Allergies in Childhood (ISAAC) at least 5 years after Phase One, to examine changes in the prevalence of symptoms of these disorders. Methods: For the ISAAC Phase Three study, between 2002 and 2003, we did a cross-sectional questionnaire survey of 193 404 children aged 6–7 years from 66 centres in 37 countries, and 304 679 children aged 13–14 years from 106 centres in 56 countries, chosen from a random sample of schools in a defined geographical area. Findings: Phase Three was completed a mean of 7 years after Phase One. Most centres showed a change in prevalence of 1 or more SE for at least one disorder, with increases being twice as common as decreases, and increases being more common in the 6–7 year age-group than in the 13–14 year age-group, and at most levels of mean prevalence. An exception was asthma symptoms in the older age-group, in which decreases were more common at high prevalence. For both age-groups, more centres showed increases in all three disorders more often than showing decreases, but most centres had mixed changes. Interpretation: The rise in prevalence of symptoms in many centres is concerning, but the absence of increases in prevalence of asthma symptoms for centres with existing high prevalence in the older age-group is reassuring. The divergent trends in prevalence of symptoms of allergic diseases form the basis for further research into the causes of such disorders.en_GB
dc.language.isoenen_GB
dc.publisherElsevieren_GB
dc.rightsinfo:eu-repo/semantics/restrictedAccessen_GB
dc.subjectAsthma -- Case studiesen_GB
dc.subjectPediatric respiratory diseasesen_GB
dc.subjectEczema in childrenen_GB
dc.subjectRhinitisen_GB
dc.titleWorldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood : ISAAC Phases One and Three repeat multicountry cross-sectional surveysen_GB
dc.typearticleen_GB
dc.rights.holderThe copyright of this work belongs to the author(s)/publisher. The rights of this work are as defined by the appropriate Copyright Legislation or as modified by any successive legislation. Users may access this work and can make use of the information contained in accordance with the Copyright Legislation provided that the author must be properly acknowledged. Further distribution or reproduction in any format is prohibited without the prior permission of the copyright holder.en_GB
dc.contributor.corpauthorISAAC Phase Three Study Groupen_GB
dc.description.reviewedpeer-revieweden_GB
dc.publication.titleThe Lanceten_GB
Appears in Collections:Scholarly Works - FacM&SMed

Files in This Item:
File Description SizeFormat 
Worldwide time trends in the prevalence of symptoms of asthma.pdf
  Restricted Access
3.02 MBAdobe PDFView/Open Request a copy


Items in OAR@UM are protected by copyright, with all rights reserved, unless otherwise indicated.